|
Promising New Treatment for Chronic Fatigue Syndrome |
The message below contains our updated website information, please send your questions to my email at alexgonzalez@miami.edu .
The Behavioral Medicine Research Center at the University of Miami is conducting a study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. Dr. Barry Hurwitz Ph.D. and Dr. Nancy Klimas M.D. are the principal investigators of this study. The study is investigating a very promising potential treatment for Chronic Fatigue Syndrome (CFS). The study is a placebo-controlled clinical trial in which Procrit is prescribed to the participants for 13 weeks. Procrit is a drug that has been used for over a decade to treat anemia which is low red blood cell volume. The drug increases the production of red blood cells, which we have discovered is low in many CFS patients. Because the red blood cell delivers oxygen to the body, it is projected that this treatment may reduce the debilitating fatigue experienced by individuals with CFS.
You can visit our web page that describes the study and also has links for downloading our brochure, as well as the electronic forms that we use to determine eligibility. The web site for our department, which is the Behavioral Medicine Department, is http://www.bmrc.miami.edu